Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  1,118 results for ""Xenograft Model Antitumor Assays""

Your Filters

Subject : carcinoma, squamous cell
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Oncolytic activity of a coxsackievirus B3 strain in patient-derived cervical squamous cell carcinoma organoids and synergistic effect with paclitaxel.

  • Authors : Lin Y; Department of Obstetrics and Gynecology, Zhongshan Hospital, Xiamen University, Xiamen, 361004, China.; Liu N

Subjects: Paclitaxel*/Paclitaxel*/Paclitaxel*/pharmacology ; Paclitaxel*/Paclitaxel*/Paclitaxel*/therapeutic use ; Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/virology

  • Source: Virology journal [Virol J] 2024 Oct 05; Vol. 21 (1), pp. 245. Date of Electronic Publication: 2024 Oct 05.Publisher: BioMed Central Country of Publication: England NLM ID: 101231645 Publication Model: Electronic Cited Medium:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Anti-CD44 Variant 10 Monoclonal Antibody Exerts Antitumor Activity in Mouse Xenograft Models of Oral Squamous Cell Carcinomas.

  • Authors : Ishikawa K; Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Miyagi, Japan.; Department of Otolaryngology, Head and Neck Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Miyagi, Japan.

Subjects: Hyaluronan Receptors*/Hyaluronan Receptors*/Hyaluronan Receptors*/metabolism ; Hyaluronan Receptors*/Hyaluronan Receptors*/Hyaluronan Receptors*/immunology ; Mouth Neoplasms*/Mouth Neoplasms*/Mouth Neoplasms*/drug therapy

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Aug 24; Vol. 25 (17). Date of Electronic Publication: 2024 Aug 24.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Astaxanthin Synergizes with Ionizing Radiation (IR) in Oral Squamous Cell Carcinoma (OSCC).

  • Authors : Du Y; Department of Otorhinolaryngology Head and Neck Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; Shuai Y

Subjects: Xanthophylls*/Xanthophylls*/Xanthophylls*/pharmacology ; Mouth Neoplasms*/Mouth Neoplasms*/Mouth Neoplasms*/radiotherapy ; Mouth Neoplasms*/Mouth Neoplasms*/Mouth Neoplasms*/pathology

  • Source: Molecular biotechnology [Mol Biotechnol] 2024 May; Vol. 66 (5), pp. 1220-1228. Date of Electronic Publication: 2023 Dec 16.Publisher: Springer Country of Publication: Switzerland NLM ID: 9423533 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Differential Angiogenic Potential of 3-Dimension Spheroid of HNSCC Cells in Mouse Xenograft.

  • Authors : Choi SY; Department of Oral and Maxillofacial Surgery, School of Dentistry, Kyungpook National University, Daegu 41940, Korea.; Kang SH

Subjects: Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/*pathology ; Head and Neck Neoplasms/Head and Neck Neoplasms/Head and Neck Neoplasms/*pathology ; Mouth Neoplasms/Mouth Neoplasms/Mouth Neoplasms/*pathology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2021 Jul 31; Vol. 22 (15). Date of Electronic Publication: 2021 Jul 31.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Suppression of KIF22 Inhibits Cell Proliferation and Xenograft Tumor Growth in Tongue Squamous Cell Carcinoma.

  • Authors : Liu Y; Department of Stomatology, Tianjin First Central Hospital, No. 24, Fukang Road, Nankai District, Tianjin 300192, China.; Li RH

Subjects: Xenograft Model Antitumor Assays*; Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/*metabolism ; Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/*pathology

  • Source: BioMed research international [Biomed Res Int] 2020 Jan 21; Vol. 2020, pp. 6387545. Date of Electronic Publication: 2020 Jan 21 (Print Publication: 2020).Publisher: Hindawi Pub. Co Country of Publication: United States NLM ID: 101600173 Publication Model: eCollection Cited

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Disulfiram with or without metformin inhibits oesophageal squamous cell carcinoma in vivo.

  • Authors : Jivan R; The School of Molecular and Cell Biology, University of the Witwatersrand, Johannesburg, Private Bag X3, WITS 2050, South Africa.; Peres J

Subjects: Xenograft Model Antitumor Assays*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*pharmacology ; Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/*drug therapy

  • Source: Cancer letters [Cancer Lett] 2018 Mar 28; Vol. 417, pp. 1-10. Date of Electronic Publication: 2017 Dec 20.Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin.

  • Authors : Wang X; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia.; Beitler JJ

Subjects: Xenograft Model Antitumor Assays*; Biphenyl Compounds/Biphenyl Compounds/Biphenyl Compounds/*pharmacology ; Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/*therapy

  • Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Feb 15; Vol. 24 (4), pp. 858-869. Date of Electronic Publication: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Inhibition of BMP signaling overcomes acquired resistance to cetuximab in oral squamous cell carcinomas.

  • Authors : Yin J; Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Republic of Korea; Rare Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.

Subjects: Xenograft Model Antitumor Assays*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*pharmacology ; Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/*drug therapy

  • Source: Cancer letters [Cancer Lett] 2018 Feb 01; Vol. 414, pp. 181-189. Date of Electronic Publication: 2017 Nov 15.Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Effects of checkpoint kinase 1 inhibition by prexasertib on the tumor immune microenvironment of head and neck squamous cell carcinoma.

  • Authors : Chaudhary R; Department of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, Florida, USA.; Slebos RJC

Subjects: Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/*prevention & control ; Checkpoint Kinase 1/Checkpoint Kinase 1/Checkpoint Kinase 1/*antagonists & inhibitors ; Head and Neck Neoplasms/Head and Neck Neoplasms/Head and Neck Neoplasms/*prevention & control

  • Source: Molecular carcinogenesis [Mol Carcinog] 2021 Feb; Vol. 60 (2), pp. 138-150. Date of Electronic Publication: 2020 Dec 30.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8811105 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Focal adhesion kinase (FAK) inhibitor-defactinib suppresses the malignant progression of human esophageal squamous cell carcinoma (ESCC) cells via effective blockade of PI3K/AKT axis and downstream molecular network.

  • Authors : Zhang L; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing, China.; Zhao D

Subjects: Benzamides/Benzamides/Benzamides/*pharmacology ; Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/*prevention & control ; Esophageal Neoplasms/Esophageal Neoplasms/Esophageal Neoplasms/*prevention & control

  • Source: Molecular carcinogenesis [Mol Carcinog] 2021 Feb; Vol. 60 (2), pp. 113-124. Date of Electronic Publication: 2020 Dec 06.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8811105 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  1,118 results for ""Xenograft Model Antitumor Assays""